Effects of ?-3 polyunsaturated fatty acid supplementation on depressive symptoms, cognition conditions and plasma metabolome in adolescent patients with depressive disorder

Shanghai Jiao Tong University0 个研究点目标入组 66 人开始时间: 2022年3月12日最近更新: 2022年9月12日

试验速览

暂无简介。

•Current inclusion criteria as of 30/08/2022:
•1. Meet the diagnostic criteria of International Classification of Diseases (ICD-10) for depressive disorder
•2. Aged 13-24 years
•3. Never received antidepressant medication, or have not received antidepressant medication within 2 weeks
•4. The patient's family members or legal guardians fully understood the content of this study and signed informed consent
•Previous inclusion criteria:
•1. The diagnostic criteria of International Classification of Diseases (ICD-10) for depressive disorder
•2. 14-25 years old
•3. Never received antidepressant medication, or have not received antidepressant medication within 2 weeks
•4. The patient's family members or legal guardians fully understood the content of this study and signed informed consent

•1. People diagnosed with bipolar disorder or other according to the ICD-10
•2. A recent or past history of alcohol and drug dependence, other psychiatric disorders, eating disorders or mental retardation
•3. Serious or chronic physical disease, endocrine disease or organic brain diseases
•4. Regular consumption of ?-3 PUFA supplements or eating fish equal to or more than 4 times per week
•5. Conducting additional clinical trials within 4 weeks prior to the start of this study

发起方

Shanghai Jiao Tong University